FOLH1 and posterior cortical atrophy: Similarly, in PCa patients, both [177Lu]Lu-PSMA-I&T and [177Lu]Lu-PSMA-617 are reported to be safe and well tolerated with only minor and easily manageable side effects [24, 25].